title: Clinical effectiveness and cost-consequences of selective serotonin reuptake inhibitors in the treatment of sex offenders.
authors.affiliation: West Midlands Health Technology Assessment Collaboration, Department of Public Health and Epidemiology, University of Birmingham, UK.
authors.forename: Y
authors.initials: Y
authors.lastname: Adi
authors.forename: D
authors.initials: D
authors.lastname: Ashcroft
authors.forename: K
authors.initials: K
authors.lastname: Browne
authors.forename: A
authors.initials: A
authors.lastname: Beech
authors.forename: A
authors.initials: A
authors.lastname: Fry-Smith
authors.forename: C
authors.initials: C
authors.lastname: Hyde
mesh_terms: D000726:Androgen Antagonists / Q000191:economics / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D017373:Cyproterone Acetate / Q000191:economics / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D017367:Selective Serotonin Reuptake Inhibitors / Q000191:economics / Q000627:therapeutic use; D012742:Sex Offenses; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D017373:Cyproterone Acetate; D017367:Selective Serotonin Reuptake Inhibitors